首页> 外文期刊>Neurology International >Oromandibular dystonia in Yemeni patients with khat chewing: a response to botulinum toxin treatment
【24h】

Oromandibular dystonia in Yemeni patients with khat chewing: a response to botulinum toxin treatment

机译:也门卡塔叶咀嚼患者的下颌肌张力障碍:对肉毒杆菌毒素治疗的反应

获取原文
获取外文期刊封面目录资料

摘要

Khat-( Catha edulis ) related oromandibular dystonia is a difficult-to-treat subset of movement disorders that involve masticatory muscles with diverse and incapacitating manifestations. The aim of this study was to evaluate the efficacy of Botulinum toxin-type A therapy in khat chewer Yemeni patients with oromandibular dystonia. This prospective study included 18 khat-chewers Yemeni patients with refractory oromandibular dystonia, who were subjected to Botulinum toxin-A injection and followed up for 3 months thereafter. Primary efficacy outcome was the global impression scale, and secondary outcome measure was the Unified Dystonia Rating Scale. Patients showed improvement of both efficacy measures, maximum satisfactory responses were detected at the forth week after injection. No major adverse events were detected. Botulinum toxin-A is considered an effective and safe treatment option for refractory oromandibular dystonia in khat-chewers.
机译:Khat(Catha edulis)相关的口腔下颌肌张力障碍是运动障碍的难于治疗的亚型,其涉及咀嚼肌具有多种多样且无能为力的表现。这项研究的目的是评估A型肉毒杆菌毒素治疗也门卡塔尔咀嚼也门颌肌肌张力障碍患者的疗效。这项前瞻性研究纳入了18名卡塔尔咀嚼也门难治性眶下肌肌张力障碍患者,他们接受了肉毒杆菌毒素A注射,随后进行了3个月的随访。主要疗效结果是总体印象量表,次要结果量度是统一的肌张力障碍评定量表。患者显示两种功效指标均得到改善,注射后第四周检测到最大满意的反应。没有发现重大不良事件。肉毒杆菌毒素-A被认为是卡塔尔咀嚼器中难治性眶下肌张力障碍的一种有效且安全的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号